Profile of humoral and cellular immune responses to single doses of BNT162b2 or ChAdOx1 nCoV-19 vaccines in residents and staff within residential care homes (VIVALDI): an observational study.

Research paper from Europe PMC. Evidence status: source reported.

Published

2021-08-19

Source reference

MED:34430954

DOI

10.1016/s2666-7568(21)00168-9

Jurisdiction

Not assessed

Licence

Bibliographic metadata only; article rights retained

Tut G, Lancaster T, Krutikov M, Sylla P, Bone D, Kaur N, Spalkova E, Bentley C, Amin U, Jadir AT, Hulme S, Butler MS, Ayodele M, Bruton R, Shrotri M, Azmi B, Fuller C, Irwin-Singer A, Hayward A, Copas A, Shallcross L, Moss P. · Lancet Healthy Longev · research support, non-u.s. gov't; research-article; journal article; observational study · Found via: ClinicalTrials.gov result publication

Source: https://europepmc.org/article/MED/34430954. Captured 2026-10-29.

Limitations: Listed by a ClinicalTrials.gov registration as a result publication of that study, and fetched by its PubMed ID. The registry's listing is the sponsor's statement; it does not confirm which data the paper used. Preprints may not be peer reviewed.